BIO

PLBIOTN00029

Biotechnology & Medical Research

Market Closed - Warsaw S.E. Other stock markets 16:55:40 17/05/2024 BST			5-day change	1st Jan Change
3.55 ^PLN	+0.28%		0.00%	-0.56%

05-17	BIOTON S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-28	BIOTON S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

BIOTON Seeks Investor For SciGen Stake

December 13, 2017 at 05:00 am

BIOTON S.A. (WSE:BIO) is looking for investor which would be willing to acquire its stake in SciGen Ltd (ASX:SIE).

Latest news about BIOTON S.A.

BIOTON S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-17	CI
BIOTON S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
BIOTON S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	31/10/23	CI
BIOTON S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23	CI
BIOTON S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23	CI
BIOTON S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
BIOTON S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	31/10/22	CI
BIOTON S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	31/08/22	CI
BIOTON S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22	CI
BIOTON S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	29/10/21	CI
Bioton S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	31/08/21	CI
Bioton S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	30/04/21	CI
Yifan Pharmaceutical Co., Ltd. completed the acquisition of 19.79% stake in BIOTON S.A. from Ningbo Free Trade Zone Dongren Investment Co., Ltd.	29/10/19	CI
Yifan Pharmaceutical Co., Ltd. completed the acquisition of 11.86% stake in BIOTON S.A. from Kelipond Investment Limited.	29/10/19	CI
Yifan Pharmaceutical Co., Ltd. signed an agreement to acquire 11.86% stake in BIOTON S.A. from Kelipond Investment Limited for approximately CNY 270 million.	02/09/19	CI
Yifan Pharmaceutical Co., Ltd. agreed to acquire 19.79% stake in BIOTON S.A. from Ningbo Free Trade Zone Dongren Investment Co., Ltd. for approximately CNY 450 million.	02/09/19	CI
YiFan International Pharmaceutical Co., Limited completed the acquisition of SciGen Ltd from BIOTON S.A. and others.	06/08/18	CI
YiFan International Pharmaceutical Co., Limited made a pre conditional offer to acquire SciGen Ltd from BIOTON S.A. and others for $28 million.	15/05/18	CI
BIOTON Seeks Investor For SciGen Stake	13/12/17	CI
Medwise Pharmaceuticals Limited completed the acquisition of Tricel S.A. from BIOTON S.A..	02/12/17	CI
BIOTON S.A.(WSE:BIO) dropped from S&P Global BMI Index	18/09/17	CI
BIOTON S.A. signed a preliminary agreement to acquire Tricel S.A. from BIOTON S.A..	23/04/17	CI
Marvel Bioscience Limited completed the acquisition of an additional 50% stake in M.J. Bioton Life Sciences Ltd. from BIOTON S.A..	30/12/16	CI
Perfect Trend Ventures Limited acquired 9.99% stake in BIOTON S.A..	04/12/16	CI
Bioton S.A. Reports Consolidated and Company Earnings Results for the Third Quarter and Nine Months Ended September 30, 2016	26/11/16	CI

Bioton SA is a Poland-based company active in the pharmaceutical sector. The Company is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The Company's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.

Sector

Biotechnology & Medical Research

Calendar

26/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
BIOTON S.A.	-0.56%	77.76M
VERTEX PHARMACEUTICALS INCORPORATED	+9.42%	115B
REGENERON PHARMACEUTICALS, INC.	+11.84%	106B
ARGENX SE	-1.05%	21.96B
BIONTECH SE	-14.15%	21.84B
GENMAB A/S	-5.29%	19.21B
BEIGENE, LTD.	-4.16%	18.08B
WUXI APPTEC CO., LTD.	-38.29%	17.71B
NEUROCRINE BIOSCIENCES, INC.	+7.99%	14.32B
SAREPTA THERAPEUTICS, INC.	+36.24%	12.42B